Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Joseph Tkacz, MS
Director of Analytics
Health Analytics
Columbia, MD
Director of Analytics, Health Analytics, Columbia, MD
Authored Items
Novel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid Arthritis
Joseph Tkacz, MS
,
Sharon Glave Frazee, PhD, MPH
,
Michael P. Ingham, MSc
,
Brenna L. Brady, PhD
,
Roxanne Meyer, PharmD
,
Charles Ruetsch, PhD
December 2015 Vol 8, No 9
in
Clinical
,
Original Research
Infliximab Dosing Patterns in a Sample of Patients with Crohn’s Disease: Results from a Medical Chart Review
Joseph Tkacz, MS
,
Atheer A. Kaddis, PharmD
,
Jennifer H. Lofland, PharmD, MPH, PhD
,
Julie Vanderpoel, PharmD, MPA
,
Charles Ruetsch, PhD
April 2014 Vol 7, No 2
in
Clinical
Last modified: January 27, 2016